Cambridge Nutritional Sciences PLC (CNSL) has received a major shareholding notification confirming that Julian Hanton crossed the 5% voting rights threshold on 5 November 2026. According to the TR-1 form filed with the FCA, Hanton now holds 12,000,000 shares, equating to 5.043062% of voting rights in the company. The notification was triggered by an acquisition of voting rights, with shares held through nominees Hargreaves Lansdown (Nominees) Limited and Pershing Nominees Limited. Investors tracking the company's shareholder register may note this as a meaningful shift in the composition of its significant shareholders.

Key Points

  • Cambridge Nutritional Sciences PLC (CNSL) — AIM-listed nutritional sciences company
  • Julian Hanton crossed the 5% voting rights threshold on 5 November 2026 via acquisition of voting rights
  • Hanton now holds 12,000,000 shares, representing 5.043062% of voting rights, up from a previous position of 4.959011%
  • Investors should watch for any further threshold crossings or changes to the company's major shareholder base

Julian Hanton's Stake in Cambridge Nutritional Sciences Rises Above 5%

The TR-1 notification, submitted on 5 November 2026, confirms that Julian Hanton's total position in Cambridge Nutritional Sciences PLC has risen to 5.043062% of voting rights, up from a previously notified position of 4.959011%. This increase was the result of an acquisition of voting rights rather than any financial instrument or structural event. The shares carry ISIN code GB00B1VCP282 and are classified as direct voting rights under DTR5.1, with the total number of voting rights held standing at 12,000,000. No financial instruments form any part of the notified position.

Shares Held via Hargreaves Lansdown and Pershing Nominees

The 12,000,000 shares attributed to Julian Hanton are held indirectly through two nominee entities: Hargreaves Lansdown (Nominees) Limited, registered in Bristol, and Pershing Nominees Limited, registered in Liverpool. The notification confirms that Hanton is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in Cambridge Nutritional Sciences. The TR-1 form also confirms no proxy voting arrangements are in place. This nominee structure is a common arrangement for retail and institutional investors managing holdings through UK platform and custody providers.

What the Threshold Crossing Means Under FCA Disclosure Rules

Under the FCA's Disclosure Guidance and Transparency Rules, any person whose voting rights cross a notifiable threshold — including the 5% level — must notify both the issuer and the FCA promptly. Cambridge Nutritional Sciences received this notification on the same date the threshold was crossed, 5 November 2026, satisfying the same-day disclosure requirement. The company, which focuses on nutritional science products, is therefore required to make this holding public via a Regulatory News Service announcement. No guidance, financial results, or operational updates accompanied this disclosure.

No Change to Cambridge Nutritional Sciences' Business Operations Disclosed

The announcement contains no information relating to Cambridge Nutritional Sciences' trading performance, revenue, product pipeline, or strategic direction. The sole purpose of the filing is regulatory disclosure of a major holding under DTR5. The company did not disclose any figures relating to revenues, earnings, or guidance in this announcement. Investors monitoring CNSL should be aware that this notification reflects a shareholder movement only, with no accompanying commentary on the company's operational or financial outlook from either the company or the notifying party.